A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis
{{output}}
Background: Chimeric antigen receptor T cell (CAR-T) therapy for relapsed/refractory (r/r) B cell acute lymphoblastic leukemia (B-ALL) and B cell non-Hodgkin lymphoma (B-NHL) patients has shown promising effects, but side effects... ...
